Clinical Trials Update: Feb. 18, 201102/18/11
(HealthDay News) -- Here are the latest clinical trials,
This study of two topical gels is for people who have blotchy,
red skin across the face from rosacea. The trial will last for 12
weeks, with four office visits.
The research site is in Plano, Texas.
This study for people 18 and older will evaluate a once-daily
investigational drug for ulcerative colitis. This study will last
for 14 months.
The research site is in Sandy, Utah.
This study will evaluate an investigational medication for
schizophrenia. Candidates must be 18 to 64 and currently being
treated with Zyprexa, Risperdal or Abilify. The research site is in
Cherry Hill, N.J.
ClinicalConnection.com. All rights reserved.
Copyright © 2011
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.